Palmitoylethanolamide (PEA) as a Potential Therapeutic Agent in Alzheimer’s Disease

Frontiers in Pharmacology - Switzerland
doi 10.3389/fphar.2019.00821
Full Text
Abstract

Available in full text

Categories
Pharmacology
Date
Authors
Publisher

Frontiers Media SA

Related search

sFRP-mediated WNT Sequestration as a Potential Therapeutic Target for Alzheimer’s Disease

International Journal of Biochemistry and Cell Biology
BiochemistryCell Biology
2016English

YKL-40 as a Potential Biomarker and a Possible Target in Therapeutic Strategies of Alzheimer’s Disease

Current Neuropharmacology
MedicinePsychiatryMental HealthNeurologyPharmacology
2017English

Memantine Prodrug as a New Agent for Alzheimer’s Disease

Scientific Reports
Multidisciplinary
2019English

Interleukin-32: Its Role in Asthma and Potential as a Therapeutic Agent

Respiratory Research
PulmonaryRespiratory Medicine
2018English

Grape Seed Polyphenolic Extract as a Potential Novel Therapeutic Agent in Tauopathies

Journal of Alzheimer's Disease
GerontologyClinical PsychologyMental HealthPsychiatryGeriatricsMedicineNeuroscience
2009English

Nicotine as a Potential Neuroprotective Agent for Parkinson's Disease

Movement Disorders
Neurology
2012English

MicroRNAs as Potential Therapeutic Targets in Kidney Disease

Journal of the Formosan Medical Association = Taiwan yi zhi
Medicine
2013English

Hypnotism as a Therapeutic Agent.

The Lancet
Medicine
1890English

Removal of Aβ Oligomers From the Blood: A Potential Therapeutic System for Alzheimer’s Disease

Neuropsychiatric Disease and Treatment
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy